Paid Breast Cancer Clinical Trials
Breast cancer clinical trials actively recruiting. Access innovative therapies including immunotherapy and targeted treatments. Compensation provided for qualified participants.
Compensation
$1,500 - $5,000
Duration
24-96 weeks
Phase
Phase II/III
FDA Regulated
IRB Approved
GCP Certified
Who May Qualify
- Age 18 years or older
- Histologically confirmed breast cancer
- Specific tumor characteristics (ER+, PR+, HER2+ or triple-negative depending on study)
- ECOG performance status 0-1
- Adequate organ function as determined by lab tests
- Willingness to provide tumor tissue samples
Who May Not Qualify
- Untreated brain metastases
- Prior treatment with specific investigational agents (study-dependent)
- Active autoimmune disease requiring systemic treatment
- Pregnancy or breastfeeding
- Uncontrolled concurrent illness
Frequently Asked Questions
What types of breast cancer treatments are being studied?
+
Current trials are investigating immunotherapies, targeted therapies like CDK4/6 inhibitors, antibody-drug conjugates, and combination regimens. Studies are available for early-stage, locally advanced, and metastatic breast cancer.
Can I participate if I have already received chemotherapy?
+
Many studies specifically enroll patients who have received prior treatments. Some trials are designed for patients whose cancer has progressed after standard therapies.
Will genetic testing be required?
+
Some studies require tumor genetic profiling or germline testing (like BRCA). This testing is typically provided at no cost as part of the screening process.
How will study participation affect my regular oncology care?
+
The study team coordinates closely with your oncologist. Many patients continue seeing their regular doctors while participating, and all medical information is shared between care teams.